Skip to main content
PMC home page
Frontiers in Neuroscience logoLink to Frontiers in Neuroscience
. 2023 Mar 2;17:1131214. doi: 10.3389/fnins.2023.1131214

The effects of resistance exercise on cognitive function, amyloidogenesis, and neuroinflammation in Alzheimer’s disease

Caroline Vieira Azevedo 1,†, Debora Hashiguchi 1,2,†, Henrique Correia Campos 1, Emilly V Figueiredo 1, Sthefanie Ferreira S D Otaviano 1, Arlete Rita Penitente 1,3, Ricardo Mario Arida 1, Beatriz Monteiro Longo 1,*
PMCID: PMC10017453  PMID: 36937673

Abstract

With the increasing prevalence of Alzheimer’s disease (AD) and difficulties in finding effective treatments, it is essential to discover alternative therapies through new approaches. In this regard, non-pharmacological therapies, such as physical exercise, have been proposed and explored for the treatment of AD. Recent studies have suggested that resistance exercise (RE) is an effective strategy for promoting benefits in memory and cognitive function, producing neuroprotective and anti-inflammatory effects, and reducing amyloid load and plaques, thereby reducing the risk, and alleviating the neurodegeneration process of AD and other types of dementia in the elderly. In addition, RE is the exercise recommended by the World Health Organization for the elderly due to its benefits in improving muscle strength and balance, and increasing autonomy and functional capacity, favoring improvements in the quality of life of the elderly population, who is more likely to develop AD and other types of dementia. In this mini-review, we discuss the impact of RE on humans affected by MCI and AD, and animal models of AD, and summarize the main findings regarding the effects of RE program on memory and cognitive functions, neurotrophic factors, Aβ deposition and plaque formation, as well as on neuroinflammation. Overall, the present review provides clinical and preclinical evidence that RE plays a role in alleviating AD symptoms and may help to understand the therapeutic potential of RE, thereby continuing the advances in AD therapies.

Keywords: Alzheimer’s disease, resistant physical exercise, neuroprotection, animal models of AD, patients with AD

1. Introduction

Alzheimer’s disease (AD) is a neurodegenerative disorder clinically characterized by progressive deficit in cognitive function and emotional behavior, mainly resulting from selective neuronal dysfunction, synaptic loss and neuroinflammation (Hebert et al., 1995). The extensive deposition of amyloid-β peptide (Aβ) in the form of senile plaques in the cortex and hippocampus and the presence of neurofibrillary tangles are the main pathophysiological characteristics of AD. In addition, AD is strongly associated with inflammatory processes resulting in neurotoxicity (Citron, 2010; Duncan and Valenzuela, 2017). With the exponential growth of the elderly population, AD presents a broad spectrum of neuropathological changes and associated risk factors. Demographic projections suggest that the disease accounts for 60-70% of dementia cases worldwide, and with increasing life expectancy, the number of AD cases has gradually increased, with an estimated 150 million cases by 2050 (Rosenberg et al., 2020; World Health Organization [WHO], 2022). Despite great advances in AD research, significant efficacy in the treatment or prevention of the disease has not yet been achieved.

Loss of strength and muscle atrophy (sarcopenia) occur frequently in the elderly and individuals with AD (Beeri et al., 2021). The consequences of this loss of function and muscle sarcopenia lead to greater difficulty in being physically active, and interfere with quality of life, thus being a major concern for the clinical population with AD and other types of dementia, such as mild cognitive impairment (MCI) (Beeri et al., 2021).

Recent studies have consistently demonstrated the beneficial effects of physical exercise on the neuropathology of AD (Kametani and Hasegawa, 2018). Among several proposed physical interventions, resistance exercise (RE) is the recommended exercise for older people, according to the World Health Organization (Bull et al., 2020). RE is characterized by contractions of specific muscles against external resistance, and has emerged as an essential strategy to improve muscle mass and strength, bone density, and power of the overall body composition, as well as functional capacity and balance, thereby attenuating or even reversing sarcopenia and reducing difficulties in task performance (Lopez et al., 2018; Smith et al., 2022).

In addition to its physical benefits, RE has been proposed to improve cognitive function and memory in the elderly and AD patients (Ozkaya et al., 2005; Cassilhas et al., 2007; Liu-Ambrose et al., 2012; Almeida et al., 2022). Moreover, RE produces neuroprotective effects, thereby increasing the release of neurotrophic factors, promoting neurogenesis, modulating inflammatory responses, and reducing Aβ load in humans with AD (Navarro et al., 2018; Almeida et al., 2022). Thus, insights into the effects of RE on AD will be helpful in understanding how it could interfere with the affected brain, regarding its effects on memory and cognitive functions, neurotrophic factors, Aβ deposition and plaque formation, and neuroinflammation. In this review, we discuss the impact of RE and its ability to alleviate the pathogenesis of AD in humans affected by MCI and AD, and in experimental animal models of AD, focusing on the main studies that have addressed these issues (Figure 1).

FIGURE 1.

FIGURE 1

Open in a new tab

Graphic abstract of the effects of RE in AD brain (created with BioRender.com).

1.1. Effects of RE on cognitive function and memory in AD

Interest in RE as a strategy for treating or preventing MCI and AD has grown since recent studies have shown its effectiveness in treating cognitive function and memory in patients with MCI or AD (Table 1; Vital et al., 2012; Fiatarone Singh et al., 2014; Brinke et al., 2015; Hong et al., 2017; Mavros et al., 2017; Tsai et al., 2018; Broadhouse et al., 2020). Among them, the study by Hong et al. (2017) showed that RE recovered cognitive function in elderly patients with MCI. This study demonstrated the effectiveness of RE in these patients, proving that RE frequency, intensity, and duration are important factors to consider. Moreover, six months of RE significantly improved memory performance, attention, and executive functions (Fiatarone Singh et al., 2014; Mavros et al., 2017), and protected the hippocampus from the degeneration that occurs in AD (Broadhouse et al., 2020). These benefits persisted for 12 months after the end of the training period (Fiatarone Singh et al., 2014; Broadhouse et al., 2020). These findings emphasize the therapeutic potential of RE for the prevention and treatment of MCI and AD.

TABLE 1.

Summary of studies using RE in patients with MCI or AD and in animal models of AD.

RE studies in MCI or AD patients
Age
(years)		 Health
status		 Sample size/
Group		 Intervention
duration		 Intensity Frequency/
Week		 Series/
Exercise		 RE short term
changes		 References
69.5 ± 6.6 MCI 13-22 6 months High (80% of peak capacity) 2/3 3x 8 of 5/6 exercises ↑ Cortical and hippocampal thickness Broadhouse et al., 2020
≥ 55 MCI 17-27 6 months High (80-92% of 1 maximum repetitions) 2/3 3x 8 of 5/6 exercises ↑ Body strenght
Cognitive improvement		 Mavros et al., 2017
≥ 55 MCI 22-27 6 months High (↑) 2/3 3x 8 of 5/6 exercises Mixed memory outcomes
Cognitive and executive improvement		 Fiatarone Singh et al., 2014
70-80 women MCI 08-27 6 months 13-15 Borg’s RPE scale 2 2x 6-8 of 7 exercises No differerence in hippocampal volume Brinke et al., 2015
75.53 ± 4.48 MCI 10-13 12 weeks 65% of 1RM 2 15 maximum repetitions no info about exercises ↑ Physical fitness
↑ Body muscular strengh
No effect in general cognition but working memory improvement		 Hong et al., 2017
Not informed AD 17 16 weeks 85% of 20 maximum repetitions 3 2x 20 + 1x until fatigue No difference in cognition and memory Vital et al., 2012
60-80 MCI 20-25 1 day 75% of 1 maximal repetition 1 2x 10 of 6 exercises ↑ serum IGF-1 Tsai et al., 2018
RE studies in AD animal models
Animal model Age (months) Sample size/
Group 		Intervention duration Intensity Frequency/
Week 		Repetitions RE changes
Female D-GAL (Wistar) 6-7 8 6 weeks Load increasing from 50-100% of body mass 3 8 Muscle hypertrophy
Cognitive improvement
↓ hippocampal and cortex Aβ
No difference in hippocampal BDNF
↑ serum IGF-1 (not in the brain)		 Özbeyli et al., 2017
Male APP/PS1 (C57Bl/6) 6-7 05-15 4 weeks Load increasing from 75-100% of maximal load 5 2x each % body mass + 100% +3g until falied ↓ hyperlocomotion
↓ hippocampal Aβ plaques volume
↓ hippocampal microglia around Aβ plaques
↓ hippocampal pro-inflammatory IL-1α, IL-6 cytokines
↓ hippocampal anti-inflammatory IL-4 cytokine		 Hashiguchi et al., 2020
Male
treated with STZ (Wistar)		 Adults
 Not informed 8 weeks Load increasing from 30-150% of body mass 3 Not informed Memory improvement
↑ hippocampal BDNF and NGF and NT3
↑ hippocampal TrkA and TrkB		 Jafarzadeh et al., 2021
Male 3xTg-AD (mice) 3 10 9 weeks Load increasing from 50- 100% of body mass 3 16-10 ↑ gastrocnemius mass
↑ grip strenght
↓ hippocampus Aβ load
No difference in BDNF
↑ IGF-1		 Pena et al., 2020
Male 3xTg Psen (B6) mice 9 07-08 4 weeks Load increasing from 15- 75% of body mass 3 15 Cognitive improvement
↓ frontal cortex and hippocampal Aβ plaques
↓ frontal cortex total and phosphorilated tau
↓ hippocampal phosphorilated tau
↓ frontal cortex and hippocampal micróglia
↓ frontal cortex and hippocampal microglia cell body
↑ hippocampal anti-inflammatory IL-10 cytokine
↓ serum IL-1β cytokine
↑ frontal cortex and hippocampal pro-inflammatory IL-6 cytokine		 Liu et al., 2020
Open in a new tab

Studies in animal models of AD have also shown the positive effects of RE on memory deficits and cognitive dysfunction (Table 1; Özbeyli et al., 2017; Liu et al., 2020; Pena et al., 2020; Jafarzadeh et al., 2021). Liu et al. found that RE could improve cognitive function in AD mice by reducing amyloid load and tau pathology, and attenuating neuroinflammation. These authors proposed that one of the mechanisms by which RE promotes these beneficial effects is an increase in pre-synaptic structural proteins involved in recycling vesicles consequently improving synaptic transmission (Liu et al., 2020). In another study, Pena et al. found that RE induced mechanisms of neuronal protection and reduction of Aβ load in the hippocampus, which in turn could improve learning and memory processing (Pena et al., 2020). Özbeyli et al. (2017) showed that the improvement in working memory provided by RE may occur via oxidative stress and the antioxidant system. Another study by Jafarzadeh et al. (2021) used a model of intraventricular injection of streptozotocin (STZ) in rats and observed that RE improved learning and memory, together with an increase in the expression of neurotrophic factors and their respective receptors. Although by different mechanisms, these studies showed improvements in memory and cognitive deficits in AD experimental models, and corroborate the results from studies with MCI patients.

Interestingly, these and other studies have shown that RE combined with aerobic exercise yields good results in improving memory and cognitive functions and minimizing AD pathophysiology (Hong et al., 2017; Özbeyli et al., 2017; De la Rosa et al., 2020; Pena et al., 2020; Huuha et al., 2022). Although only few studies have investigated the effects of RE on memory deficits presented in MCI and AD (Table 1), conventional aerobic exercise protocols have been extensively explored to investigate this issue (Sousa et al., 2021; Almeida et al., 2022). Considerable individual differences related to the degree and severity of AD pathology in memory and cognitive performance may be partially explained by the concept of cognitive reserve, which describes the brain’s functional ability to adapt and compensate for damage. Furthermore, considering that memory improvement is related to the formation of new hippocampal neurons, as shown in physically active AD animals, studies have proposed that exercise-induced neurogenesis may improve memory and help recovering from cognitive deficits that occur in AD (Mirochnic et al., 2009; Tapia-Rojas et al., 2016; Gaitán et al., 2021). Thus, increased cognitive reserve may help explain the reduced risk of AD in exercised patients and animals (Huuha et al., 2022). Therefore, it is plausible that the combination of different exercise modalities is more efficient in increasing cognitive reserve and neurogenesis than exercise programs with a single type of exercise.

1.2. Influence of RE on neurotrophic factors in AD

The direct action of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) on neuronal survival and plasticity has led to the investigation of these neurotrophins in AD, as neuronal death and synaptic loss are among the main neuropathological features of the disease. It has been shown that in neuronal culture, the availability of BDNF and NGF increases the viability of cells previously exposed to the Aβ peptide. Conversely, a decrease in the availability of BDNF and TrkA receptors, which impairs NGF signaling, increases Aβ and Tau levels. These studies suggest that BDNF and NGF are both involved in amyloid precursor protein (APP) processing (for review see Gao et al., 2022). In vivo studies corroborate these findings and provide evidence for the benefits of neurotrophic factors in neuronal survival. While low levels of BDNF are associated with cognitive deficits and impaired memory and learning (Capsoni et al., 2000; Heldt et al., 2007), increasing BDNF levels in AD animals prevents neuronal loss and improves cognitive performance (Nagahara et al., 2009, 2013; Jiao et al., 2016; Gao et al., 2022). Despite these positive results, other studies have not systematically shown direct interference of BDNF and NGF in the formation of Aβ plaques and neurofibrillary tangles in the development of AD (Capsoni et al., 2000; Arancibia et al., 2008; Castello et al., 2012; Xiong et al., 2015; Braun et al., 2017; Wang et al., 2019), which can be explained by the differences in animal models or methodologies employed.

RE applied in old animals or animal models of AD, using exercise programs lasting between 4 and 12 weeks, increased BDNF levels in the hippocampus (Özbeyli et al., 2017; Vilela et al., 2017; Jafarzadeh et al., 2021; Kim et al., 2021; Lee et al., 2022; Rahmati et al., 2022). Two of these studies also showed increased levels of exercise-induced NGF (Jafarzadeh et al., 2021; Rahmati et al., 2022), whereas Pena et al. found no difference in BDNF levels in the brain of resistance-trained animals (Pena et al., 2020). Human studies investigating the effects of RE in the elderly population have indicated that programs with 12 weeks to 6 months of exercise increase peripheral BDNF levels (Roh et al., 2020; Deus et al., 2021; Castaño et al., 2022). Furthermore, higher BDNF levels were observed after a single RE session (Arazi et al., 2021).

In addition to BDNF and NGF, insulin-like growth factor 1 (IGF-1) is also down-regulated in AD. It has been shown that IGF-1 plays a role in the clearance of Aβ plaques in the cortex and hippocampus (Carro et al., 2002; Talbot et al., 2012). Furthermore, cerebral uptake of IGF-1 increased BDNF mRNA expression (Carro et al., 2002). These studies suggest an inverse correlation between IGF-1 levels and Aβ load and a direct correlation between IGF-1 and BDNF levels in the brain.

Regular physical exercise stimulates synthesis and increases IGF-1 levels, mediates hippocampal neurogenesis, and induces neuroprotection (Carro et al., 2002; Cassilhas et al., 2007; Chang et al., 2012). Importantly, the low IGF-1 levels present in the brain of patients with MCI can be elevated with the practice of RE, helping to increase synaptic plasticity, neuronal survival, and cognitive performance, consequently improving AD pathophysiology (Tsai et al., 2018; Ribariè, 2022). Furthermore, RE elevated the levels of IGF-1 and BDNF by enhancing muscle strength (Burns et al., 2010; Mavros et al., 2017), increasing neurogenesis, and ameliorating insulin sensitization (Kim and Song, 2018; Lourenco et al., 2020). Studies using animal models of AD have also shown that RE helps to increase IGF-1 signaling and reduce APP mRNA and Aβ levels. (Özbeyli et al., 2017; Pena et al., 2020). These results suggest that RE affects the modulation of neurotrophic factors, which in turn plays a protective role in AD pathology, reducing the toxicity resulting from Aβ load in the brain.

When both types of exercise were compared, studies have suggested that RE elevates the levels of IGF-1 more than BDNF in the hippocampus and peripheral blood, whereas aerobic exercise preferentially increase BDNF more than IGF-1 (Cassilhas et al., 2012, Tsai et al., 2018). However, in the study by Pena et al. with 3X-tgAD mice subjected to aerobic exercise and RE, although a concomitant reduction in Aβ load with an increase in IGF-1 levels was observed in the RE group, no significant change was observed in hippocampal BDNF levels under either exercise condition (aerobic or RE). Interestingly, in human studies, serum concentrations of BDNF and VEGF in elderly individuals with MCI increased after acute aerobic exercise but not after acute RE (Tsai et al., 2018). Although the potential mechanisms of the benefits of different types of exercise are not yet clear (Balbim et al., 2022), studies have proposed that RE is likely to exert its effects via mechanisms distinct from those of aerobic exercise (Tsai et al., 2018).

1.3. Effects of RE on amyloid load and Aβ plaques in the AD brain

Although the pathological mechanism of AD is not yet well understood, the theory of the Aβ protein as a triggering agent is well accepted. In recent decades, several studies have indicated that the accumulation of Aβ can precede the clinical symptoms of the disease by years, in addition to triggering exacerbated inflammatory processes and accelerating tau pathology. In addition, the intracellular increase in oligomeric forms of Aβ preceding the formation of extracellular Aβ plaques has been proposed as a key early event in AD progression (for review see Huuha et al., 2022).

Evidence consistently indicates an inverse correlation between exercise and amyloid load in AD animals, regardless of the type, intensity, and duration of exercise, and stage of the disease (Zhang J. et al., 2018; Brown et al., 2019; Almeida et al., 2022). Human studies also show an inverse correlation between plasma and brain levels of Aβ and physical activity in the elderly with AD or MCI (for review see De la Rosa et al., 2020), although few studies have found no evidence that exercise reduces Aβ or relieves amyloid pathology (Huuha et al., 2022).

In animal models, RE was able to promote the clearance of Aβ (Özbeyli et al., 2017; Liu et al., 2020; Pena et al., 2020), reduce the volume (Hashiguchi et al., 2020), and number of Aβ plaques (Liu et al., 2020), and reduce tau pathology in the brain (Liu et al., 2020). Accordingly, in the study by Pena et al. there was a reduction in the expression of Aβ peptide, although the levels of the protein APP did not decrease in the hippocampus of 3xTg-AD mice exercised by RE (Pena et al., 2020).

Several mechanisms by which exercise alleviates amyloid pathology have been proposed, including the downregulation of the enzymes responsible for the formation of Aβ (Alkadhi and Dao, 2018; Zhang X. et al., 2018), modulation of microglial activity (Hashiguchi et al., 2020; Liu et al., 2020), and reduction of astrogliosis (Liu et al., 2020). However, as previously suggested, Aβ levels are resistant to clearance once they reach a severity threshold with age (Intlekofer and Cotman, 2013), and exercise may have a greater effect on amyloid pathology in the early stages of the disease (Huuha et al., 2022). Moreover, the benefits of exercise in modulating the burden of Aβ in the pathology of AD may be dependent on the type of exercise, and the stage of the disease, as they can promote similar benefits through different mechanisms and response windows to induce a modifier effect on Aβ (Hashiguchi et al., 2020).

In general, as in RE, it has also been shown that aerobic exercise contributes to the reduction of Aβ load, and size and quantity of Aβ plaques, which consequently improves memory (Tapia-Rojas et al., 2016; Lu et al., 2017; Choi et al., 2018). In contrast, some studies on aerobic exercise in animal models of AD, as in humans, did not find a decrease in the Aβ plaques (Ke et al., 2011), or reduced only in younger but not in older mice (Zhao et al., 2015). Accordingly, although physical exercise induced positive effects on synapse strength, redox homeostasis, and general brain function, it was not able to reduce the hippocampal levels of Aβ deposition (García-Mesa et al., 2011). Interestingly, when comparing both aerobic and RE training, Pena et al. observed a reduction in Aβ levels in RE but not in aerobic exercised AD mice, which suggests that it would be reasonable to combine RE with other types of physical exercise as a more effective therapeutic strategy in reducing Aβ.

1.4. RE modulating inflammatory responses in AD

An exacerbated inflammatory response in the brain of patients with cognitive dysfunction has been observed, and has been identified as a risk factor for neurodegenerative diseases (Intlekofer and Cotman, 2013). In AD, elevated levels of pro-inflammatory cytokines, such as IL-1β, IL-6, IL-12, IL-18, TNF-α, and IFNγ, have been observed in both patients and AD experimental models in rodents (Alvarez et al., 2007; Bronzuoli et al., 2016; Wu et al., 2018; Jensen et al., 2019; Hashiguchi et al., 2020; Li et al., 2020; Liu et al., 2020). Additionally, a lower ability to clear Aβ plaques is associated with an increase in the levels of IL-1β and TNF-α (Heneka et al., 2015), which may impair hippocampal function (Intlekofer and Cotman, 2013), corroborating the idea that pro-inflammatory cytokines induce cognitive decline and memory loss in AD (Sousa et al., 2021; Almeida et al., 2022).

In animal models of AD, RE was shown to inhibit the secretion of pro-inflammatory cytokines, probably by modifying microglial activation in the hippocampus (Hashiguchi et al., 2020; Liu et al., 2020) and frontal cortex, and improving the cognitive performance of transgenic mice for AD (Liu et al., 2020). Hashiguchi et al. showed that RE restored the levels of pro-inflammatory IL-1α and IL-6 and anti-inflammatory IL-4 cytokines to control levels (Hashiguchi et al., 2020). Using a different RE protocol, Liu et al. showed that RE was able to decrease the levels of pro-inflammatory cytokines (TNF-α and IL-1β mRNA), inhibiting pro-inflammatory intracellular pathways (Liu et al., 2020). These results corroborate the results of human studies using the RE program in patients with MCI, therefore proposing the exercise as a modulator of systemic inflammation, which could explain the neuroprotective effect of the exercise (for review see Almeida et al., 2022; Huuha et al., 2022). Similar to RE, when considering aerobic exercise, studies with patients with AD have shown that, after performing an aerobic program, there was a reduction in inflammatory parameters in association with clinical improvements (Jensen et al., 2019; Li et al., 2020).

2. Conclusion

As shown in this mini-review, interest in RE for preventing, treating, or slowing the neuropathological conditions of AD has begun to attract researchers’ attention owing to a growing body of evidence showing the effectiveness of this type of exercise in patients with MCI and AD, and AD models in rodents. RE has been proposed as a promising strategy for reducing Aβ deposition and plaques, neurofibrillary tangles, and neuroinflammation, as well as for increasing levels of neurotrophic factors and neurogenesis, leading to improvements in memory deficits and cognitive decline. According to the WHO, RE is the recommended exercise for older people due to its effects on reducing difficulties in functional capacity, besides its benefits in muscle strengthening, better postural stability, and reduced risk of falls.

Given this scenario, RE can be proposed for patients with AD, as an alternative and adjuvant therapy, as a possible therapeutic strategy, not only to improve symptoms, but also to prevent or control the progression of neurodegeneration in AD. Considering the need to find effective strategies to decelerate the progress or even prevent AD and other types of dementia, RE seems to have preventive potential, alone or in combination with other types of exercise, thereby increasing the chance of positive results with conventional therapies and helping improve the quality of life of these patients. Moreover, insights into the effects of RE on AD may help understand the therapeutic potential of RE and the mechanisms for improving or stabilizing the disease, continuing the advances in AD therapies.

Author contributions

DH, AP, EF, and BL wrote the first draft of the manuscript. CA, HC, EF, SO, and RA contributed to the article’s literature search. RA and BL contributed to the conception. DH, AP, EF, CA, HC, SO, RA, and BL contributed to the revision of the manuscript. All authors contributed to the article and approved the submitted version.

Acknowledgments

The authors acknowledge Christiane Gimenes and Viviam Sababria for the technical support, Prof. Dr. Paulo Bertolucci for the helpful discussions, and FAPESP and CNPq for the financial support. We also acknowledge the CEDEME animal facility (Centro de Desenvolvimento de Modelos Experimentais para Biologia e Medicina) for providing us with the double-transgenic APPswe/PS1dE9 mice.

Funding Statement

This work was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP grant #2022/00249-8), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brazil (CAPES; Finance Code 001) (CAPES-PRINT #88881.310490/2018-01), and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq #408676/2018-3 and #312904/2021-5).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  1. Alkadhi K., Dao A. (2018). Exercise decreases BACE and APP levels in the hippocampus of a rat model of Alzheimer’s disease. Mol. Cell Neurosci. 86 25–29. 10.1016/j.mcn.2017.11.008 [DOI] [PubMed] [Google Scholar]
  2. Almeida E., Ibrahim H., Chitolina Schetinger M., de Andrade C., Cardoso A. (2022). Modulation of Inflammatory Mediators and microglial activation through physical exercise in Alzheimer’s and Parkinson’s diseases. Neurochem. Res. 47 3221–3240. 10.1007/s11064-022-03713-x [DOI] [PubMed] [Google Scholar]
  3. Alvarez A., Cacabelos R., Sanpedro C., García-Fantini M., Aleixandre M. (2007). Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol. Aging 28 533–536. 10.1016/j.neurobiolaging.2006.02.012 [DOI] [PubMed] [Google Scholar]
  4. Arancibia S., Silhol M., Moulière F., Meffre J., Höllinger I., Maurice T., et al. (2008). Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol. Dis. 31 316–326. 10.1016/j.nbd.2008.05.012 [DOI] [PubMed] [Google Scholar]
  5. Arazi H., Babaei P., Moghimi M., Asadi A. (2021). Acute effects of strength and endurance exercise on serum BDNF and IGF-1 levels in older men. BMC Geriatr. 21:50. 10.1186/s12877-020-01937-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Balbim G., Falck R., Barha C., Starkey S., Bullock A., Davis J., et al. (2022). Effects of exercise training on the cognitive function of older adults with different types of dementia: a systematic review and meta-analysis. Br. J. Sports Med. [Epub ahead of print]. 10.1136/bjsports-2021-104955 [DOI] [PubMed] [Google Scholar]
  7. Beeri M., Leugrans S., Delbono O., Bennett D., Buchman A. (2021). Sarcopenia is associated with incident Alzheimer’s dementia, mild cognitive impairment, and cognitive decline. J. Am. Geriatr. Soc. 69 1826–1835. 10.1111/jgs.17206 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Braun D., Kalinin S., Feinstein D. (2017). Conditional depletion of hippocampal brain-derived neurotrophic factor exacerbates neuropathology in a mouse model of Alzheimer’s Disease. ASN Neuro. 9:1759091417696161. 10.1177/1759091417696161 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brinke L., Bolandzadeh N., Nagamatsu L., Hsu C., Davis J., Miran-Khan K., et al. (2015). Aerobic exercise increases hippocampal volume in older women with probable mild cognitive impairment: a 6-month randomised controlled trial. Br. J. Sports Med. 49 248–254. 10.1136/bjsports-2013-093184 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Broadhouse K. M., Singh M. F., Suo C., Gates N., Wen W., Brodaty H., et al. (2020). Hippocampal plasticity underpins long-term cognitive gains from resistance exercise in MCI. NeuroImage 25:102182. 10.1016/j.nicl.2020.102182 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bronzuoli M. R., Iacomino A., Steardo L., Scuderi C. (2016). Targeting neuroinflammation in Alzheimer’s disease. J. Inflamm. Res. 9 199–208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Brown A. F., Ma G. X., Miranda J., Eng E., Castille D., Brockie T., et al. (2019). Structural interventions to reduce and eliminate health disparities. Am. J. Public Health 109 S72–S78. 10.2105/AJPH.2018.304844 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bull F. C., Al-Ansari S. S., Biddle S., Borodulin K., Buman M. P., Cardon G., et al. (2020). World health organization 2020 guidelines on physical activity and sedentary behaviour. Br. J. Sports Med. 54, 1451–1462. 10.1136/bjsports-2020-102955 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Burns J., Johnson D., Watts A., Swerdlow R., Brooks W. (2010). Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch. Neurol. 67 428–433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Capsoni S., Ugolini G., Comparini A., Ruberti F., Berardi N., Cattaneo A. (2000). Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 97 6826–6831. 10.1073/pnas.97.12.6826 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Carro E., Trejo J. L., Gomez-Isla T., LeRoith D., Torres-Aleman I. (2002). Serum insulin-like growth factor I regulates brain amyloid-β levels. Nat. Med. 8 1390–1397. 10.1038/nm1202-793 [DOI] [PubMed] [Google Scholar]
  17. Cassilhas R., Lee K., Fernandes J., Oliveira M., Tufik S., Meeusen R., et al. (2012). Spatial memory is improved by aerobic and resistance exercise through divergent molecular mechanisms. Neuroscience 202 309–317. 10.1016/j.neuroscience.2011.11.029 [DOI] [PubMed] [Google Scholar]
  18. Cassilhas R., Viana V., Grassmann V., Santos R., Santos R., Tufik S., et al. (2007). The impact of resistance exercise on the cognitive function of the elderly. Med. Sci. Sports Exerc. 39 1401–1407. 10.1249/mss.0b013e318060111f [DOI] [PubMed] [Google Scholar]
  19. Castaño L., Castillo de Lima V., Barbieri J., de Lucena E., Gáspari A., Arai H., et al. (2022). Resistance training combined with cognitive training increases brain derived neurotrophic factor and improves cognitive function in healthy older adults. Front. Psychol. 13:870561. 10.3389/fpsyg.2022.870561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Castello N., Green K., LaFerla F. (2012). Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Aβ or tau pathology. PLoS One 7:e39566. 10.1371/journal.pone.0039566 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Chang Y., Pan C., Chen F., Tsai C., Huang C. (2012). Effect of resistance-exercise training on cognitive function in healthy older adults: a review. J. Aging Phys. Act. 20 497–517. 10.1123/japa.20.4.497 [DOI] [PubMed] [Google Scholar]
  22. Choi S., Bylykbashi E., Chatila Z., Lee S., Pulli B., Clemenson G., et al. (2018). Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer’s mouse model. Science 361:eaan8821. 10.1126/science.aan8821 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Citron M. (2010). Alzheimer’s disease: strategies for disease modification. Nat. Rev. 9 387–398. 10.1038/nrd2896 [DOI] [PubMed] [Google Scholar]
  24. De la Rosa A., Olaso-Gonzalez G., Arc-Chagnaud C., Millan F., Salvador-Pascual A., García-Lucerga C., et al. (2020). Physical exercise in the prevention and treatment of Alzheimer’s disease. J. Sport Health Sci. 9 394–404. 10.1016/j.jshs.2020.01.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Deus L., Corrêa H., Neves R., Reis A., Honorato F., Silva V., et al. (2021). Are resistance training-induced BDNF in hemodialysis patients associated with depressive symptoms, quality of life, antioxidant capacity, and muscle strength? An insight for the muscle-brain-renal axis. Int. J. Environ. Res. Public Health 18:11299. 10.3390/ijerph182111299 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Duncan T., Valenzuela M. (2017). Alzheimer’s disease, dementia, and stem cell therapy. Stem Cell Res. Ther. 8:111. 10.1186/s13287-017-0567-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Fiatarone Singh M., Gates N., Saigal N., Wilson G., Meiklejohn J., Brodaty H., et al. (2014). The study of mental and resistance training (SMART) study-resistance training and/or cognitive training in mild cognitive impairment: a randomized, double-blind, double-sham controlled trial. JAMDA 15 873–880. 10.1016/j.jamda.2014.09.010 [DOI] [PubMed] [Google Scholar]
  28. Gaitán J., Moon H., Stremlau M., Dubal D., Cook D., Okonkwo O., et al. (2021). Effects of aerobic exercise training on systemic biomarkers and cognition in late middle-aged adults at risk for Alzheimer’s Disease. Front. Endocrinol. 12:660181. 10.3389/fendo.2021.660181 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Gao L., Zhang Y., Sterling K., Song W. (2022). Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential. Transl. Neurodegener. 11:4. 10.1186/s40035-022-00279-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. García-Mesa Y., López-Ramos J., Giménez-Llort L., Revilla S., Guerra R., Gruart A., et al. (2011). Physical exercise protects against Alzheimer’s disease in 3xTg-AD mice. J. Alzheimers Dis. 24 421–454. 10.3233/JAD-2011-101635 [DOI] [PubMed] [Google Scholar]
  31. Hashiguchi D., Campos H., Wuo-Silva R., Faber J., Gomes da Silva S., Coppi A., et al. (2020). Resistance exercise decreases amyloid load and modulates inflammatory responses in the APP/PS1 mouse model for Alzheimer’s Disease. J. Alzheimers Dis. 73 1525–1539. [DOI] [PubMed] [Google Scholar]
  32. Hebert L. E., Scherr P. A., Beckett L. A., Albert M. S., Pilgrim D. M., Chown M. J., et al. (1995). Age-specific incidence of Alzheimer’s disease in a community population. Jama 273 1354–1359. [PubMed] [Google Scholar]
  33. Heldt S., Stanek L., Chhatwal J., Ressler K. (2007). Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol. Psychiatry 12 656–670. 10.1038/sj.mp.4001957 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Heneka M., Carson M., El Khoury J., Landreth G., Brosseron F., Feinstein D., et al. (2015). Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 14 388–405. 10.1016/S1474-4422(15)70016-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Hong S., Kim J., Jun T. (2017). Effects of 12-week resistance exercise on electroencephalogram patterns and cognitive function in the elderly with mild cognitive impairment: a randomized controlled trial. Clin. J. Sport Med. 28 500–508. 10.1097/JSM.0000000000000476 [DOI] [PubMed] [Google Scholar]
  36. Huuha A., Norevik C., Moreira J., Kobro-Flatmoen A., Scrimgeour N., Kivipelto M., et al. (2022). Can exercise training teach us how to treat Alzheimer’s disease? Ageing Res. Rev. 75:101559. 10.1016/j.arr.2022.101559 [DOI] [PubMed] [Google Scholar]
  37. Intlekofer K., Cotman C. (2013). Exercise counteracts declining hippocampal function in aging and Alzheimer’s disease. Neurobiol. Dis. 57 47–55. 10.1016/j.nbd.2012.06.011 [DOI] [PubMed] [Google Scholar]
  38. Jafarzadeh G., Shakerian S., Farbood Y., Ghanbarzadeh M. (2021). Effects of eight weeks of resistance exercises on neurotrophins and trk receptors in alzheimer model male wistar rats. Basic Clin. Neurosci. 12 349–360. 10.32598/bcn.2021.2067.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Jensen C., Bahl J., Østergaard L., Høgh P., Wermuth L., Heslegrave A., et al. (2019). Exercise as a potential modulator of inflammation in patients with Alzheimer’s disease measured in cerebrospinal fluid and plasma. Exp. Gerontol. 121 91–98. 10.1016/j.exger.2019.04.003 [DOI] [PubMed] [Google Scholar]
  40. Jiao S., Shen L., Zhu C., Bu X., Liu Y., Liu C., et al. (2016). Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer’s disease. Transl. Psychiatry 6:e907. 10.1038/tp.2016.186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Kametani F., Hasegawa M. (2018). Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer’s Disease. Front. Neurosci. 12:25. 10.3389/fnins.2018.00025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Ke H., Huang H., Liang K., Hsieh-Li H. (2011). Selective improvement of cognitive function in adult and aged APP/PS1 transgenic mice by continuous non-shock treadmill exercise. Brain Res. 1403 1–11. 10.1016/j.brainres.2011.05.056 [DOI] [PubMed] [Google Scholar]
  43. Kim O., Song J. (2018). The role of irisin in Alzheimer’s disease. J. Clin. Med. 7:407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Kim S., Hwang L., Jin J., Ko I., Kim Y., Yoon H., et al. (2021). Resistance exercise improves spatial learning ability through phosphorylation of 5’-adenosine monophosphate-activated protein kinase in parkinson disease mice. Int. Neurourol. J. 25(Suppl. 2), S55–S62. 10.5213/inj.2142336.168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lee G., Kim Y., Jang J., Lee C., Yoon J., Ahn N., et al. (2022). Effects of an exercise program combining aerobic and resistance training on protein expressions of neurotrophic factors in obese rats injected with beta-amyloid. Int. J. Environ. Res. Public Health 19:7921. 10.3390/ijerph19137921 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Li Z., Chen Q., Liu J., Du Y. (2020). Physical exercise ameliorates the cognitive function and attenuates the neuroinflammation of Alzheimer’s disease via miR-129-5p. Dement Geriatr. Cogn. Disord. 49, 163–169. 10.1159/000507285 [DOI] [PubMed] [Google Scholar]
  47. Liu Y., Chu J., Yan T., Zhang Y., Chen Y., Chang R., et al. (2020). Short-term resistance exercise inhibits neuroinflammation and attenuates neuropathological changes in 3xTg Alzheimer’s disease mice. J. Neuroinflamm. 17:4. 10.1186/s12974-019-1653-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Liu-Ambrose T., Nagamatsu L., Voss M., Khan K., Handy T. (2012). Resistance training and functional plasticity of the aging brain: a 12-month randomized controlled trial. Neurobiol. Aging 33 1690–1698. 10.1016/j.neurobiolaging.2011.05.010 [DOI] [PubMed] [Google Scholar]
  49. Lopez P., Pinto R., Radaelli R., Rech A., Grazioli R., Izquierdo M., et al. (2018). Benefits of resistance training in physically frail elderly: a systematic review. Aging Clin. Exp. Res. 30 889–899. 10.1007/s40520-017-0863-z [DOI] [PubMed] [Google Scholar]
  50. Lourenco M., Ribeiro F., Sudo F., Drummond C., Assunção N., Vanderborght B., et al. (2020). Cerebrospinal fluid irisin correlates with amyloid-β, BDNF, and cognition in Alzheimer’s disease. Alzheimers Dement. 12:e12034. 10.1002/dad2.12034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Lu Y., Dong Y., Tucker D., Wang R., Ahmed M., Brann D., et al. (2017). Treadmill exercise exerts neuroprotection and regulates microglial polarization and oxidative stress in a streptozotocin-induced rat model of sporadic Alzheimer’s Disease. J. Alzheimers Dis. 56 1469–1484. 10.3233/JAD-160869 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Mavros Y., Gates N., Wilson G., Jain N., Meiklejohn J., Brodaty H., et al. (2017). Mediation of cognitive function improvements by strength gains after resistance training in older adults with mild cognitive impairment: outcomes of the study of mental and resistance training. J. Am. Geriatr. Soc. 65 550–559. 10.1111/jgs.14542 [DOI] [PubMed] [Google Scholar]
  53. Mirochnic S., Wolf S., Staufenbiel M., Kempermann G. (2009). Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease. Hippocampus 19 1008–1018. 10.1002/hipo.20560 [DOI] [PubMed] [Google Scholar]
  54. Nagahara A., Mateling M., Kovacs I., Wang L., Eggert S., Rockenstein E., et al. (2013). Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice. J. Neurosci. 33 15596–15602. 10.1523/JNEUROSCI.5195-12.2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Nagahara A., Merrill D., Coppola G., Tsukada S., Schroeder B., Shaked G., et al. (2009). Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease. Nat. Med. 15 331–337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Navarro V., Sanchez-Mejias E., Jimenez S., Muñoz-Castro C., Sanchez-Varo R., Davila J. C., et al. (2018). Microglia in Alzheimer’s Disease: activated, dysfunctional or degenerative. Front. Aging Neurosci. 10:140. 10.3389/fnagi.2018.00140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Özbeyli D., Sari G., Özkan N., Karademir B., Yüksel M., Kaya Ö. T. Ç., et al. (2017). Protective effects of different exercise modalities in an Alzheimer’s disease-like model. Behav. Brain Res. 328, 159–177. 10.1016/j.bbr.2017.03.044 [DOI] [PubMed] [Google Scholar]
  58. Ozkaya G. Y., Aydin H., Toraman F. N., Kizilay F., Ozdemir O., Cetinkaya V. (2005). Effect of strength and endurance training on cognition in older people. J. Sports Sci. Med. 4 300–313. [PMC free article] [PubMed] [Google Scholar]
  59. Pena G. S., Paez H. G., Johnson T. K., Halle J. L., Carzoli J. P., Visavadiya N. P., et al. (2020). Hippocampal growth factor and myokine cathepsin b expression following aerobic and resistance training in 3xTg-AD Mice. Int. J. Chronic Dis. 2020:5919501. 10.1155/2020/5919501 [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Rahmati M., Keshvari M., Xie W., Yang G., Jin H., Li H., et al. (2022). Resistance training and Urtica dioica increase neurotrophin levels and improve cognitive function by increasing age in the hippocampus of rats. Biomed. Pharmacother. 153:113306. 10.1016/j.biopha.2022.113306 [DOI] [PubMed] [Google Scholar]
  61. Ribariè S. (2022). Physical exercise, a potential non-pharmacological intervention for attenuating neuroinflammation and cognitive decline in Alzheimer’s Disease patients. Int. J. Mol. Sci. 23:3245. 10.3390/ijms23063245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Roh H., Cho S., So W. Y. A. (2020). Cross-sectional study evaluating the effects of resistance exercise on inflammation and neurotrophic factors in elderly women with obesity. J. Clin. Med. 9:842. 10.3390/jcm9030842 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Rosenberg A., Mangialasche F., Ngandu T., Solomon A., Kivipelto M. (2020). Multidomain interventions to prevent cognitive impairment, Alzheimer’s Disease, and dementia: from FINGER to world-wide FINGERS. J. Prev. Alzheimers Dis. 7 29–36. 10.14283/jpad.2019.41 [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Smith C., Woessner M., Sim M., Levinger I. (2022). Sarcopenia definition: does it really matter? Implications for resistance training. Ageing Res. Rev. 78:101617. 10.1016/j.arr.2022.101617 [DOI] [PubMed] [Google Scholar]
  65. Sousa R., Rodrigues C., Mendes B., Improta-Caria A., Peixoto M., Cassilhas R. (2021). Physical exercise protocols in animal models of Alzheimer’s disease: a systematic review. Metab. Brain Dis. 36 85–95. 10.1007/s11011-020-00633-z [DOI] [PubMed] [Google Scholar]
  66. Talbot K., Wang H., Kazi H., Han L., Bakshi K., Stucky A., et al. (2012). Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin Invest. 122 1316–1338. 10.1172/JCI59903 [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Tapia-Rojas C., Aranguiz F., Varela-Nallar L., Inestrosa N. (2016). Voluntary running attenuates memory loss, decreases neuropathological changes and induces neurogenesis in a mouse model of Alzheimer’s Disease. Brain Pathol. 26 62–74. 10.1111/bpa.12255 [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Tsai C., Ukropec J., Ukropcová B., Pai M. (2018). An acute bout of aerobic or strength exercise specifically modifies circulating exerkine levels and neurocognitive functions in elderly individuals with mild cognitive impairment. NeuroImage 17 272–284. 10.1016/j.nicl.2017.10.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Vilela T., Muller A., Damiani A., Macan T., da Silva S., Canteiro P., et al. (2017). Strength and aerobic exercises improve spatial memory in aging rats through stimulating distinct neuroplasticity mechanisms. Mol. Neurobiol. 54 7928–7937. 10.1007/s12035-016-0272-x [DOI] [PubMed] [Google Scholar]
  70. Vital T. M., Hernández S. S. S., Pedroso R. V., Teixeira C. V. L., Garuffi M., Stein A. M., et al. (2012). Effects of weight training on cognitive functions in elderly with Alzheimer’s disease. Dement Neuropsychol. 6, 253–259. 10.1590/S1980-57642012DN06040009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Wang Z., Xiang J., Liu X., Yu S., Manfredsson F., Sandoval I., et al. (2019). Deficiency in BDNF/TrkB neurotrophic activity stimulates δ-secretase by upregulating C/EBPβ in Alzheimer’s Disease. Cell Rep. 28 655–69.e5. 10.1016/j.celrep.2019.06.054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. World Health Organization [WHO] (2022). Dementia. Available online at: https://www.who.int/news-room/fact-sheets/detail/dementia#:~:text=Alzheimer’s%20disease%20is%20the%20most,dependency%20among%20older%20people%20globally [Google Scholar]
  73. Wu C., Yang L., Tucker D., Dong Y., Zhu L., Duan R., et al. (2018). Beneficial effects of exercise pretreatment in a sporadic Alzheimer’s rat model. Med. Sci. Sports Exerc. 50:945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Xiong J., Li S., Sun Y., Zhang X., Dong Z., Zhong P., et al. (2015). Long-term treadmill exercise improves spatial memory of male APPswe/PS1dE9 mice by regulation of BDNF expression and microglia activation. Biol. Sport 32 295–300. 10.5604/20831862.1163692 [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Zhang J., Guo Y., Wang Y., Song L., Zhang R., Du Y. (2018). Long-term treadmill exercise attenuates Aβ burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer’s disease. Neurosci. Lett. 666 70–77. [DOI] [PubMed] [Google Scholar]
  76. Zhang X., Fu Z., Meng L., He M., Zhang Z. (2018). The early events that initiate β-amyloid aggregation in Alzheimer’s Disease. Front. Aging Neurosci. 10:359. 10.3389/fnagi.2018.00359 [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Zhao G., Liu H., Zhang H., Tong X. (2015). Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice. Neuroscience 298 357–366. 10.1016/j.neuroscience.2015.04.038 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Neuroscience are provided here courtesy of Frontiers Media SA

RESOURCES